Five months after it was declared, an Ebola outbreak in the eastern Democratic Republic of the Congo (DRC) has become the largest the country has ever recorded. As of September 27, 2026, the DRC had reported 8,116 confirmed cases and 3,924 confirmed deaths, according to the United Kingdom Health Security Agency's monitoring of official data [1]. The World Health Organization (WHO) continues to classify the outbreak as a public health emergency of international concern, the agency's highest level of alarm [1].
A different kind of Ebola
"Ebola" refers to a family of related viruses. Most recent outbreaks, including the 2014-2016 West African epidemic, were caused by the Zaire species, for which there is now an approved vaccine and two antibody treatments. This outbreak is caused by the Bundibugyo species, which had caused only two known outbreaks before: one in Uganda in 2007, with 149 suspected cases and 37 deaths, and one in the DRC in 2012, with 56 confirmed cases and 17 deaths [2]. That difference has major consequences. WHO states that there is no vaccine or specific treatment approved for Bundibugyo virus disease, although promising candidates are being tested [3]. Standard tests also played a role in the slow start. Early samples from the outbreak tested negative because the tests used only detected the Zaire species [4]. Health officials now believe the virus began spreading around February 2026, three months before the outbreak was officially declared on May 15, with early cases misdiagnosed as malaria or typhoid [5].
How the outbreak grew
When WHO first announced the outbreak on May 16, it reported eight laboratory-confirmed cases in Ituri province, one in the capital, Kinshasa, and two in Kampala, the capital of neighboring Uganda [4]. By early June, the two countries had reported more than 500 confirmed cases [6]. By late July, WHO warned that the outbreak remained out of control, with 3,605 confirmed cases and 1,587 deaths, and with record weekly case counts [7]. Ituri province remains the epicenter, with 6,182 cases, including 2,848 deaths, as of late September. Cases have been rising in North Kivu province, which had reported 1,541 cases and 914 deaths [1]. In August, WHO Director-General Tedros Adhanom Ghebreyesus said that "at its current pace," the outbreak would eclipse the 2014-2016 West African epidemic, which killed more than 11,000 people [5]. Uganda contained its part of the outbreak. It recorded 20 confirmed cases, 15 of them imported from the DRC, and two deaths. WHO and the Africa Centres for Disease Control and Prevention declared Uganda's outbreak over on August 27 [1]. In July, the U.S. Centers for Disease Control and Prevention reported that a U.S. citizen working for a humanitarian organization in the DRC had tested positive for the virus [8].
Why this outbreak is so hard to stop
Eastern Congo is one of the most difficult places in the world to fight an epidemic. WHO has pointed to the combination of armed conflict, large-scale population displacement, heavy cross-border movement and trade, and a remote but densely populated region [3][7]. Insecurity can make it dangerous for health workers to trace contacts or bury the dead safely, and displaced families moving between camps and towns can carry the virus to new areas. Ebola spreads through direct contact with the blood or body fluids of a sick person or someone who has died of the disease, which is why safe burials and infection control in clinics are central to any response. "Health workers are chasing the virus, but the virus remains ahead," Dr. Mohamed Janabi, WHO's regional director for Africa, said at a press conference in Bunia, near the epicenter [5]. The crude case fatality rate, the share of confirmed cases who have died, has hovered between roughly 40% and 50% in official data [1][7]. WHO has said community engagement will be key, noting that outbreaks are brought under control only when local communities participate in the response [3].
The search for a vaccine
Because there is no approved Bundibugyo vaccine, researchers have looked for alternatives. Experts have discussed whether Ervebo, the vaccine approved for the Zaire species, might offer any protection against Bundibugyo, and trials of experimental candidates are underway [3][4]. Clinicians also note that standard Ebola antibody treatments developed for the Zaire species are not expected to work against this strain, leaving early supportive care, such as fluids, electrolytes and treatment of complications, as the main option for patients. Researchers say early treatment in a well-equipped center can significantly improve a patient's chances of survival. Ebola cases tend to be concentrated among working-age adults. In an early CDC analysis of cases through June 2, most patients were between 18 and 49 years old, with cases roughly evenly split between women and men [2]. Health workers are also at heightened risk because they care for patients directly. The outbreak is also a reminder of how often Ebola returns to the DRC. This is the country's 17th recorded Ebola outbreak since the virus was first identified there in 1976, and it began only about five months after the previous outbreak ended [1][4].
The global response
WHO has not recommended travel or trade restrictions on the DRC or Uganda [6]. As of late September, the United Kingdom reported no imported cases linked to the outbreak [1]. The response is unfolding in a changed global health landscape: the United States, historically the largest funder of WHO and a major supporter of Ebola responses, formally completed its withdrawal from the organization in January 2026 and now directs its global health assistance through bilateral agreements. WHO said in August that it hoped to halt the outbreak's spread within three months, while cautioning that controlling transmission is not the same as ending the outbreak [5].
Why it matters
The Bundibugyo outbreak is a test of how prepared the world is for a known disease in an unfamiliar form. It shows how quickly a gap in vaccines, treatments or even diagnostic tests can turn a manageable outbreak into a regional emergency. It is also a reminder that an outbreak in a conflict zone thousands of miles away can quickly become a global concern. Research on vaccine candidates for Bundibugyo, including trials of experimental products, may determine how the world responds the next time this strain appears.
Sources
- 1. UK Health Security Agency, "Outbreaks under monitoring: week 39, 21 to 27 September 2026," updated October 1, 2026. https://www.gov.uk/government/publications/outbreaks-under-monitoring-in-2026/outbre aks-under-monitoring-week-39-week-ending-27-september-2026
- 2. CDC, "Notes from the Field: Outbreak of Ebola Disease Caused by Bundibugyo Virus — Democratic Republic of the Congo and Uganda, May 2026," Morbidity and Mortality Weekly Report. https://www.cdc.gov/mmwr/volumes/75/wr/mm7522e3.htm
- 3. World Health Organization, "Ebola outbreak — Democratic Republic of the Congo, 2026" (situation page). https://www.who.int/emergencies/situations/ebola-outbreak---drc-2026
- 4. "2026 Central Africa Ebola epidemic," Wikipedia (for early timeline; accessed October 2026). https://en.wikipedia.org/wiki/2026_Central_Africa_Ebola_epidemic
- 5. "Ebola on track to become deadliest in history: WHO chief," The Daily Observer (Bangladesh), August 13,
- 2026. https://observerbd.com/news/587821
- 6. "Ebola outbreak expands across DRC and Uganda," Open Access Government, June 2026. https://www.openaccessgovernment.org/ebola-outbreak-expands-across-drc-and-uganda/210305/
- 7. "WHO: Ebola outbreak in DR Congo spiralling out of control, risk of transmission escalating," WAM, August 2, 2026. https://www.wam.ae/en/article/17cpqr4-who-ebola-outbreak-congo-spiralling-out-control
- 8. European Centre for Disease Prevention and Control, "Ebola disease outbreak in the Democratic Republic of the Congo and Uganda," August 2026. https://www.ecdc.europa.eu/en/ebola-outbreak-democratic-republic-congo-and-uganda Information in this article is current as of October 9, 2026. Bracketed numbers refer to the sources listed above.